Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s revision indicator was updated from **v3.5.2** to **v3.5.3**. This reflects an underlying site/version change rather than a change to the trial’s content.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:29.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:35:55.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.3 to v3.5.0. This change does not affect study details or core page behavior.
    Difference
    0.1%
    Check dated 2026-03-19T05:07:15.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:41:18.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-03-04T23:24:13.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; prior updates and notices, including Revision: v3.4.1 and a government funding/operating status notice, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:20:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.